
Three Colorado Medspa Patients sickened after non-FDA-approved toxin purchased online
By Kate Dee, MD — Founder, MedSpa Board
On October 8, 2026, the CDC published a report on a Colorado medical spa where three women developed neurologic symptoms typical of botulism poisoning within 24 hours of botulinum toxin injections. Numbness and tingling. Muscle weakness. Blurred vision. Voice changes. Neck stiffness. Headache. Difficulty breathing. All three had received the same lot of a botulinum toxin product that is not approved by the FDA. The provider bought it from an online supplier.
A licensed provider, working in a medical spa, bought a neurotoxin off the internet and injected it into patients’ faces.
This is not an isolated incident, and it is not confined to unlicensed operators. Chasing the cheapest source of toxin is rampant in this industry, including among licensed providers. Enforcement agencies have only recently started paying attention. When they do, legitimate medspas get lumped in with this sordid mess.
A Phone Call to Poison Control
In January 2026, Rocky Mountain Poison and Drug Safety alerted health officials about a woman whose symptoms began the same day she received a botulinum toxin injection at a Colorado medical spa. The Colorado Department of Public Health and Environment opened an investigation with the CDC, the FDA, and the local public health agency.
Investigators texted the 52 patients who had received botulinum toxin at the spa in December 2025 and January 2026. Twenty-seven responded, and two more women with symptoms were identified. All three had been injected in the upper brow, the glabella, or the upper lip, within one day of one another, from the same lot of the same unapproved product. None of them knew it was not FDA-approved.
Their doses were 24 units, 10 units, and 3 units, according to what was reported. Three units is a tiny dose to produce blurred vision and voice changes. That alone should tell you that something was not right.
No one was hospitalized, and all three recovered. The lot they received was no longer available to test. The CDC tested a different lot from the same spa and found active botulinum toxin type A. The report lists the possible explanations for the patients’ symptoms: unknown product concentration, contamination, improper preparation, and improper administration or storage.
Colorado issued a public health order directing the provider to stop using the unapproved product and filed a complaint with the Colorado Department of Regulatory Agencies, which oversees professional licensing. In Colorado, administering a non-FDA-approved product can result in disciplinary action against a licensed provider. The spa was not named.
“Approved in another country” is not a safety net
The CDC report describes the product as approved in other countries but not in the United States. That sounds reassuring. It should not be.
Start with the obvious problem: the claim is almost impossible to verify. A product bought from an online supplier comes with whatever story the seller decides to tell. The box may look like a product sold legitimately in Korea, Europe, or South America. It may be that product. It may be a counterfeit of it. It may be a diverted lot, a relabeled lot, or something else entirely. The person holding the vial in a treatment room has no way to tell the difference.
Even if the product is exactly what the seller claims, approval somewhere else tells you nothing about what happened to that vial on its way to you. Botulinum toxin is a biologic. It has to be manufactured, shipped, and stored under controlled conditions. Nobody can document the chain of custody of a vial that came through an online marketplace. Who held it, for how long, at what temperature, and whether it was tampered with are all unknowable.
Then there is dosing. Units of botulinum toxin are not interchangeable between products. A unit of one brand is not equivalent to a unit of another, which is why each FDA-approved product has its own labeling and its own dosing. An injector using an unfamiliar foreign product, with no FDA-reviewed labeling, is guessing at potency. When the guess is wrong, toxin can spread beyond where it was injected, and the symptoms look exactly like what these three women described: weakness, blurred vision, voice changes, and trouble breathing. That is the reason every FDA-approved botulinum toxin carries a boxed warning for distant spread of toxin effect.
This has happened before. In 2024, the CDC investigated harmful reactions linked to counterfeit or mishandled botulinum toxin injections: 17 cases across 9 states, 13 of them hospitalized. Some of the products were bought through large online marketplaces rather than authorized suppliers. The CDC closed that investigation and noted it was still receiving similar reports. Colorado is one more.
The rest of the inspection report
Inspectors also cited the spa for using single-dose vials on more than one patient, reconstituting with a diluent that contained a preservative, inadequate temperature monitoring, and using reconstituted or unlabeled product past its beyond-use date.
Using a vial of toxin for more than one patient and reconstituting with bacteriostatic saline are common practice across aesthetic medicine, including in dermatology and plastic surgery offices. Both depart from the product labeling, and that is the point. Once investigators are in your clinic because of a bad product, they will read the label and write up every deviation they find. Gaps in temperature logs and labeling of reconstituted product fall in the same category: not the cause of this outbreak, but easy findings for an inspector.
None of those items is why three women developed neurologic symptoms. The unapproved product bought online is the dangerous part of the story here.
This is a federal issue too
The CDC report points out that medical spas may be regulated as dispensers under the Drug Supply Chain Security Act. That means federal law requires them to buy prescription drugs only from authorized trading partners and to be able to account for what they bought and what they gave.
The FDA has already acted on this. On April 1, 2026, it issued a warning letter to Pure Indulgence Aesthetics, a medical spa in Southlake, Texas. The spa’s patient records showed far more Botox administered than it had purchased from the manufacturer, AbbVie, and it could not explain the difference. Inspectors found an unlabeled clear vial of white powder in the trash. FDA lab testing confirmed it contained botulinum toxin. The FDA concluded the spa had obtained product from unauthorized sources and represented it to patients as authentic Botox.
Put that letter next to the Colorado report and the pattern is obvious. Regulators are counting vials and matching invoices to patient charts. Where you buy your toxin is now a question with a paper trail behind it.
What legitimate legal compliance looks like
Only FDA-approved product. Every botulinum toxin and filler used on a patient in the United States should be FDA-approved for use in the United States. Not approved somewhere else. Not “the same thing, just imported.”
Bought directly from the manufacturer. Federal law requires toxins and fillers come directly from the manufacturer, with invoices that match the lot numbers on the vials. Nothing from an online supplier, a foreign website, a social media seller, or a rep with a side deal. If the price is far below what everyone else pays, the product is the reason. If it is not approved, it does not belong in a medical practice.
A medical director must know where the products come from. In some states that is a physician, and in others an NP or PA can serve in the role. Either way, that person is responsible for protocols, product sourcing, and supervision.
What patients should know
Your provider should educate you about the different types of neurotoxins they offer and explain what the risks and benefits are. Make sure what you are getting is FDA-approved in the United States. Ask where the practice buys it. Ask to see the box or vial before it is drawn up. Look up your injector’s license. Look up the medical director too.
If the price is a bargain, ask why. If something seems off, the CDC’s advice from an earlier investigation applies: if in doubt, don’t get the injection.
If you develop drooping eyelids, blurred or double vision, slurred speech, muscle weakness, or trouble swallowing or breathing after a botulinum toxin injection, seek medical care. Trouble breathing or swallowing is an emergency. You can reach Poison Help at 1-800-222-1222, and reactions can be reported to the FDA through MedWatch.
Where MedSpa Board certification fits
This case did not involve a missing license or a fake credential. It involved a licensed provider deciding to buy a neurotoxin online. That decision is invisible to patients. The MedSpa Board makes it visible. Aesthetics and wellness practices that are MedSpa Board certified always use genuine FDA-approved products obtained from legitimate sources.
If you run a medspa and your standards are ready to be verified, begin your application now. If you want to see where you stand first, download our free checklist that tells you all the requirements to become certified.
— Kate Dee, MD
Sources & further reading
- Oruganti P, Riemer NG, et al., “Notes from the Field: Investigation of Unapproved Botulinum Toxin Product Administered at a Medical Spa — Colorado, 2025–2026,” MMWR 2026;75(39):597–599, October 8, 2026. https://www.cdc.gov/mmwr/volumes/75/wr/mm7539a2.htm
- Dorothy Brooks, “Three Colorado Women Developed Blurred Vision and Weakness After Unapproved Botulinum Toxin Shots at a Medical Spa,” Medical Daily, October 9, 2026. https://medicaldaily.com/colorado-medical-spa-unapproved-botox-symptoms-cdc-479790
- U.S. Food and Drug Administration, Warning Letter 723267 to Pure Indulgence Aesthetics, April 1, 2026. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pure-indulgence-aesthetics-723267-04012026
- Centers for Disease Control and Prevention, “Harmful Reactions Linked to Counterfeit ‘Botox’ or Mishandled Botulinum Toxin Injections.” https://www.cdc.gov/botulism/outbreaks/harmful-reactions-botox-injections.html

